News and Trends 24 Jul 2015
MGB puts a new spin on fighting multi-resistant bacteria
MGB Biopharma wants to tackle multi-resistant bacteria with their newly developed anti-infectives. Its lead candidate, MGB-BP-3 is now entering Phase I. Biotech companies use several approaches when it comes to killing bacteria, especially when these are resistant against antibiotics. In our last news, we have seen, Ferring betting on bacteriophages or ELIGO using CRISPR on this purpose. The Scottish […]